Uveitis: Pathogenesis, Clinical presentations and Treatment

  • Mustafa M
  • Muthusamy P
  • Hussain S
  • et al.
N/ACitations
Citations of this article
88Readers
Mendeley users who have this article in their library.

Abstract

Uveitis a vision threatening inflammation of uvea is prevalent worldwide. In the United States uveitis has prevalence of 2.3 million people and causes 10% of all cases of blindness. Uveitis is classified by the ocular structures involved e.g., anterior, intermediate, posterior and panuveitis.0cular TB(Eales' disease) is common in patients from Indian sub-continent. Frequent uveitis etiologies includes, Herpes simplex, Herpes zoster, cytomegalovirus, syphilis, tuberculosis, Lyme disease, toxoplasmosis and fungi. Diagnosis of uveitis is always presumptive and cannot be proved by pathology or by culture. PCR has proven most useful in diagnosis of uveitis. Treatment is mostly by acyclovir, intravenous antiviral agents, anti TB drugs for ocular tuberculosis, intravenous penicillin for ocular syphilis and sulfadiazine for Toxoplasmosis, with corticosteroids added to prevent intraocular or sight threatening inflammation. Early diagnosis and treatment of uveitis can prevent vision loss. KEYWORS: Uveitis, Acute retinal necrosis, Progressive outer retinal necrosis, Herpetic anterior uveitis, and Treatment.

Cite

CITATION STYLE

APA

Mustafa, M., Muthusamy, P., Hussain, SS., Shimmi, SC., & Sein, MM. (2014). Uveitis: Pathogenesis, Clinical presentations and Treatment. IOSR Journal of Pharmacy (IOSRPHR), 04(12), 42–47. https://doi.org/10.9790/3013-0401201042047

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free